-
Signature
-
/s/ Jeffrey E. Salvesen, Attorney-in-Fact
-
Issuer symbol
-
SCHW
-
Transactions as of
-
01 May 2025
-
Net transactions value
-
-$619,019
-
Form type
-
4
-
Filing time
-
05 May 2025, 16:01:21 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Woolway Paul V |
MD, Chief Banking Officer |
3000 SCHWAB WAY, WESTLAKE |
/s/ Jeffrey E. Salvesen, Attorney-in-Fact |
05 May 2025 |
0002031313 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SCHW |
Common Stock |
Options Exercise |
$361,616 |
+8,614 |
+34% |
$41.98 |
33,767 |
01 May 2025 |
Direct |
F1 |
| transaction |
SCHW |
Common Stock |
Sale |
$706,361 |
-8,614 |
-16% |
$82.00 |
45,824 |
01 May 2025 |
by Trust |
F1, F2, F3 |
| transaction |
SCHW |
Common Stock |
Sale |
$274,274 |
-3,380 |
-7.4% |
$81.15 |
42,444 |
01 May 2025 |
by Trust |
F2, F4 |
| holding |
SCHW |
Common Stock |
|
|
|
|
|
7,464 |
01 May 2025 |
by ESPP |
F5 |
| holding |
SCHW |
Common Stock |
|
|
|
|
|
1,139 |
01 May 2025 |
by Son 1 |
|
| holding |
SCHW |
Common Stock |
|
|
|
|
|
1,139 |
01 May 2025 |
by Son 2 |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SCHW |
Nonqualified Stock Option (right to buy) |
Options Exercise |
$0 |
-8,614 |
-50% |
$0.000000 |
8,613 |
01 May 2025 |
Common Stock |
8,614 |
$41.98 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: